A severe tremor caused by a beta2 agonist in a patient with asthma-chronic obstructive pulmonary disease overlap

被引:0
|
作者
Nakajima, Kota [1 ,2 ]
Momo, Kenji [2 ]
机构
[1] Izumi Mem Hosp, Dept Pharm, Tokyo, Japan
[2] Showa Univ, Dept Hosp Pharmaceut, Sch Pharm, Hatanodai 1-5-8,Shinagawa Ku, Tokyo 1428555, Japan
来源
CLINICAL CASE REPORTS | 2024年 / 12卷 / 08期
关键词
asthma-chronic obstructive pulmonary disease overlap; tizanidine; tremor; beta; 2; agonist; PHARMACOLOGICAL-PROPERTIES; DRUG-INTERACTION; TIZANIDINE; FORMOTEROL; EFFICACY;
D O I
10.1002/ccr3.9137
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 46-year-old male developed respiratory distress due to asthma-chronic obstructive pulmonary disease overlap and experienced severe tremor caused by beta2 agonist inhalant. We present our successful experience with tizanidine administration.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Nitrosative stress in patients with asthma-chronic obstructive pulmonary disease overlap
    Barnes, Peter J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (04) : 928 - 930
  • [22] Understanding the pathophysiology of the asthma-chronic obstructive pulmonary disease overlap syndrome
    Gelb, Arthur F.
    Nadel, Jay A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 136 (03) : 553 - 555
  • [24] THE PREVALENCE AND CHARACTERISTICS OF ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME
    Phuong Phan Thu
    Phuong Phan Thu
    Tuyet Truong Thi
    Giap Vu Van
    Hanh Chu Thi
    Chau Ngo Quy
    RESPIROLOGY, 2015, 20 : 48 - 48
  • [25] Unmet Needs and the Future of Asthma-Chronic Pulmonary Obstructive Disease Overlap
    Cazzola, Mario
    Rogliani, Paola
    Matera, Maria Gabriella
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2022, 42 (03) : 691 - 700
  • [26] Severe asthma and asthma-chronic obstructive pulmonary disease syndrome reply
    Wenzel, Sally E.
    Jayawardena, Shyamalie
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Teper, Ariel
    LANCET, 2016, 388 (10061): : 2742 - 2742
  • [27] Airway hyperresponsiveness in chronic obstructive pulmonary disease: A marker of asthma-chronic obstructive pulmonary disease overlap syndrome?
    Tkacova, Ruzena
    Dai, Darlene L. Y.
    Vonk, Judith M.
    Leung, Janice M.
    Hiemstra, Pieter S.
    van den Berge, Maarten
    Kunz, Lisette
    Hollander, Zsuzsanna
    Tashkin, Donald
    Wise, Robert
    Connett, John
    Ng, Raymond
    McManus, Bruce
    Man, S. F. Paul
    Postma, Dirkje S.
    Sin, Don D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (06) : 1571 - +
  • [28] The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations
    Louie, Samuel
    Zeki, Amir A.
    Schivo, Michael
    Chan, Andrew L.
    Yoneda, Ken Y.
    Avdalovic, Mark
    Morrissey, Brian M.
    Albertson, Timothy E.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2013, 6 (02) : 197 - 221
  • [29] Pharmacologic Management Strategies of Asthma-Chronic Obstructive Pulmonary Disease Overlap
    Hanania, Nicola A.
    Miravitlles, Marc
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2022, 42 (03) : 657 - 669
  • [30] Asthma-Chronic Obstructive Pulmonary Disease Overlap: Diagnostic and Management Challenges
    Ohar, Jill
    Putcha, Nirupama
    Bradshaw, Molly
    JOURNAL OF FAMILY PRACTICE, 2018, 67 (10): : S46 - 351